Blood Cancers | Tumor

Top 4 Stories From the 2024 ASH Annual Meeting

December 24th 2024, 4:00pm

Article

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.

Ryoncil Receives FDA Approval for Children With GVHD

December 18th 2024, 10:45pm

Article

This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.

‘Golden Bachelor’ Reveals Cancer Diagnosis, Ryne Sandberg’s Cancer Has Returned and More

December 13th 2024, 4:00pm

Article

From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the cancer space this week.

Heart Risk May Occur Less With Some BTK Inhibitors in B-Cell Blood Cancers

December 9th 2024, 11:00pm

Article

In patients with certain B-cell blood cancers, heart-related side effects may occur less after receiving second-generation BTK inhibitors.

Pregnancy-Associated Hematological Malignancies Linked With Complications

November 29th 2024, 4:00pm

Article

Researchers have found an increased frequency of severe maternal morbidity and obstetric complications among women who received a diagnosis of a hematological malignancy during pregnancy.

Identifying Cardiovascular Disease Risk in Cancer Survivors

October 22nd 2024, 9:00pm

Article

The risk of cardiovascular disease is elevated in cancer survivors, regardless of treatment, and is influenced by cancer type and treatment-related factors.

Education on MPN Symptoms, Treatments Leads to Greater Involvement in Care

October 3rd 2024, 7:00pm

Article

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.

Reblozyl May Be ‘The Standard of Care’ Now in Lower-Risk MDS, Anemia

September 24th 2024, 3:00pm

Article

An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS.

In a World of Rushing, Cancer Taught Me to Slow Down

September 20th 2024, 5:00pm

Article

With my myelodysplastic syndrome and age, I find it hard to keep up; however, cancer and fatigue have taught me to live at my own pace.

Patients With Lower-Risk Myelofibrosis May Respond to Jakafi

September 18th 2024, 9:00pm

Article

Although Jakafi has been approved for patients with higher-risk myelofibrosis, those with lower-risk disease may also benefit from this treatment.